Kodiak Turns Back On Tarcocimab After Two Pivotal Trial Flops In DME

Stock Down 46%

 
• By Ayisha Sharma
  
white arrow on road pointing towards dead-end brick wall
It Is The End Of The Road For Kodiak's Tarcocimab • Source: Shutterstock

More from Clinical Trials

More from R&D